Zilver PTX Stent Recall Issued Due to Tip Separation Risk

All Zilver PTX drug eluting stents have been recalled due to a faulty delivery system, which may not meet government standards, resulting in at least one patient death and other complaints.  

The Zilver PTX Drug Eluting Stent recall was announced by the FDA on April 24, due to the potential that the delivery system’s tip may separate from the catheter, posing a risk of removal surgery, vascular occlusion, thrombosis, amputation, cardiac arrest, and even death.

At least 13 complaints of problems with Zilver PTX stents have been received by the manufacturer, including at least 2 cases involving inner delivery catheter breakage. At least one of those patients died following the Zilver PTX stent complications.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The recalled Zilver PTX stents are small mesh tubes with an outer drug coating used to help prevent an artery from narrowing. The stents are implanted by a physician by making a small incision in the groin region where the stent is inserted and guides a catheter to the appropriate location in the artery to allow blood flow and prevent common circulatory problems.

The recall includes all sizes, diameters, and lot numbers of Zilver PTX drug eluding stent manufactured by Cook Inc. of Limerick, Ireland from December 13, 2012 through April 16, 2013. The stents were approved for sale in at least 54 countries including the United States, Japan, Australia, and Brazil.

The delivery system tip has been deemed to not meet the established design criteria and is being thoroughly investigated for further issues that may arise from the inner delivery systems and Cook Inc. announced there is a 0.043 occurrence rate that the delivery system tip may separate.

The vice president of Cook Inc. released a statement saying that if patients have had the Zilver PTX drug eluting stent implanted and the delivery system was removed, there is no risk to those patients nor to those with the “bare metal” version of Cook Medical’s Zilver Flex stent.

The FDA announced that consignees should immediately stop using the device, quarantine any remaining inventory and return it to Cook Inc. for credit. Any adverse events or problems arising from the recalled stents should be reported to Cook Medical Customer Relations at (800) 457-4500 or 1-812-339-2235 Monday through Friday between 7:30 a.m. and 5:00 p.m. Eastern time or via email at CustomerrelationsNA@cookmedical.com.

Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A Florida surgeon is standing trial over allegations that he implanted unapproved VentriO breast mesh without consent, causing severe infections, permanent nerve damage, and multiple reconstructive surgeries.
A tabletop fire pit lawsuit claims a Rhode Island man suffered catastrophic burn injuries this summer due to manufacturers ignoring safety warnings by federal regulators.